Hercules Capital’s fourth quarter results missed Wall Street’s revenue and non-GAAP profit expectations, with management pointing to robust origination activity and portfolio growth as primary drivers ...
Recently, Hercules Capital (HTGC) has seen its share price plummet. At the time of writing, the BDC is down over 16% in the past year. Typically trading at a massive premium, the price drop makes them ...
Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results